WHITEHAWK THERAPEUTICS, INC.: 10-Q filed 2012-08-14

Name: WHITEHAWK THERAPEUTICS, INC.: 10-Q filed 2012-08-14
Creator: WHITEHAWK THERAPEUTICS, INC.

What WHITEHAWK THERAPEUTICS, INC. reported in its quarterly report filed 2012-08-14 (fiscal Q2 2012): 15 published measures, 50 facts as tagged in accession 0001144204-12-045521.

This filing

Form: 10-Q (quarterly report)
Filed: 2012-08-14
Fiscal period: fiscal Q2 2012
Accession: 0001144204-12-045521 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All WHITEHAWK THERAPEUTICS, INC. filings.

Reported measures

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit	Days
At 2012-06-30	-79,841	USD
At 2011-12-31	-68,176	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit
At 2012-06-30	9,311	USD
At 2011-12-31	4,125	USD
At 2011-06-30	9,230	USD
At 2010-12-31	26,898	USD
At 2007-11-15	0	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2012-04-01 to 2012-06-30	-6,303	USD	91
2012-01-01 to 2012-06-30	-11,665	USD	182
2007-11-16 to 2012-06-30	-129,841	USD	1689
2011-04-01 to 2011-06-30	-6,760	USD	91
2011-01-01 to 2011-06-30	-11,914	USD	181

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2012-01-01 to 2012-06-30	-19,814	USD	182
2007-11-16 to 2012-06-30	-125,689	USD	1689
2011-01-01 to 2011-06-30	-17,668	USD	181

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

Period	Value	Unit	Days
2012-01-01 to 2012-06-30	25,000	USD	182
2007-11-16 to 2012-06-30	135,000	USD	1689
2011-01-01 to 2011-06-30	0	USD	181

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2012-04-01 to 2012-06-30	-5,031	USD	91
2012-01-01 to 2012-06-30	-9,262	USD	182
2007-11-16 to 2012-06-30	-121,114	USD	1689
2011-04-01 to 2011-06-30	-5,862	USD	91
2011-01-01 to 2011-06-30	-10,129	USD	181

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2012-06-30	15,561	USD
At 2011-12-31	6,625	USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

Period	Value	Unit	Days
2012-04-01 to 2012-06-30	1,272	USD	91
2012-01-01 to 2012-06-30	2,403	USD	182
2007-11-16 to 2012-06-30	8,727	USD	1689
2011-04-01 to 2011-06-30	898	USD	91
2011-01-01 to 2011-06-30	1,785	USD	181

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2012-06-30	95,402	USD
At 2011-12-31	74,801	USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

Period	Value	Unit	Days
At 2012-06-30	175	USD
At 2011-12-31	2,977	USD

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2012-06-30	5,000,000	shares
At 2011-12-31	5,000,000	shares

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

Period	Value	Unit	Days
At 2012-06-30	1,500	USD
At 2011-12-31	5,500	USD

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

Period	Value	Unit	Days
2012-04-01 to 2012-06-30	5,031	USD	91
2012-01-01 to 2012-06-30	9,262	USD	182
2007-11-16 to 2012-06-30	105,471	USD	1689
2011-04-01 to 2011-06-30	5,862	USD	91
2011-01-01 to 2011-06-30	10,129	USD	181

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

Period	Value	Unit	Days
2012-01-01 to 2012-06-30	0	USD	182
2007-11-16 to 2012-06-30	50,000	USD	1689
2011-01-01 to 2011-06-30	0	USD	181
2007-12-01 to 2007-12-31	50,000	USD	31

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

Period	Value	Unit	Days
2012-01-01 to 2012-06-30	-2,802	USD	182
2007-11-16 to 2012-06-30	175	USD	1689
2011-01-01 to 2011-06-30	136	USD	181

Inspect the source

Entity: WHITEHAWK THERAPEUTICS, INC. / CIK 0001422142
Captured: 2026-09-20T08:03:20.803Z
SEC response SHA-256: 0bc3518b433577b57088b38c087953d494e28bdd319b1da3b435ea8e7e18b0c1

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001422142.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))